Analysis of gene and protein expression during monocyte-macrophage differentiation and cholesterol loading--cDNA and protein array study.

BACKGROUND To better understand the role of macrophages in atherogenesis and to find new strategies to prevent their harmful effects, more information is needed about their gene and protein expression patterns in atherogenic conditions. METHODS We analyzed gene and protein expression changes during monocyte-macrophage differentiation and lipid-loading by cDNA arrays and antibody-based protein arrays, respectively. RESULTS It was found that early response genes, such as transcription factors, were upregulated early during monocyte-macrophage differentiation, while genes functioning in cell proliferation, migration, inflammation and lipid metabolism were activated later during macrophage differentiation. When comparing results from cDNA and antibody arrays, it become evident that changes at the protein levels were not always predicted by changes at the mRNA level. This discrepancy may be due to the different transcript variants that exist for distinct genes, posttranslational modifications and different turnover rates for mRNAs and proteins of distinct genes. When combining cDNA and protein array results with RT-PCR, it was found that CD36, COX-2, and several factors regulating cell signaling, such as Cdk-1, TFII-I, NEMO-like kinase, Elf-5 and TRADD were strongly upregulated both at the mRNA and protein levels. CONCLUSIONS Time-dependency of the activation of the early response genes and genes functioning in inflammation, lipid metabolism and cell proliferation and migration, is an important feature of the macrophage differentiation. It was also evident that several novel transcription factors were activated during lipid-loading. It is concluded that cDNA and protein arrays will be useful for the identification of genes that are potential targets for therapeutic interventions.

[1]  H. Aburatani,et al.  A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. , 2004, Journal of atherosclerosis and thrombosis.

[2]  R. Roeder,et al.  Cloning of an Inr‐ and E‐box‐binding protein, TFII‐I, that interacts physically and functionally with USF1 , 1997, The EMBO journal.

[3]  K. Matsushima,et al.  Serial analysis of gene expression in human monocytes and macrophages. , 1999, Blood.

[4]  K. Moore,et al.  Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages* , 2002, The Journal of Biological Chemistry.

[5]  P. Brown,et al.  Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.

[6]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[7]  Marina A Dobrovolskaia,et al.  Toll receptors, CD14, and macrophage activation and deactivation by LPS. , 2002, Microbes and infection.

[8]  P. Pandolfi,et al.  Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms , 2002, The Journal of cell biology.

[9]  Hans Clevers,et al.  The TAK1–NLK–MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF , 1999, Nature.

[10]  S. Gygi,et al.  Correlation between Protein and mRNA Abundance in Yeast , 1999, Molecular and Cellular Biology.

[11]  Y. Nishimune,et al.  Induction of instability of p34(cdc2) expression by treatment with cisplatin (CDDP) in mouse teratocarcinoma F9 cells. , 2002, Cancer letters.

[12]  Changes in the expression of adhesion molecules as peripheral blood monocytes differentiate into peritoneal macrophages , 1996 .

[13]  T. Kodama,et al.  Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[14]  S. Ylä-Herttuala,et al.  Functional genomics and DNA array techniques in atherosclerosis research. , 1999, Current opinion in lipidology.

[15]  S. Ylä-Herttuala,et al.  Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ , 2002, The journal of gene medicine.

[16]  S. Ylä-Herttuala,et al.  Gene Expression in Macrophage-Rich Inflammatory Cell Infiltrates in Human Atherosclerotic Lesions as Studied by Laser Microdissection and DNA Array: Overexpression of HMG-CoA Reductase, Colony Stimulating Factor Receptors, CD11A/CD18 Integrins, and Interleukin Receptors , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[17]  J. Mestre,et al.  Overlapping CRE and E‐box promoter elements can independently regulate COX‐2 gene transcription in macrophages , 2001, FEBS letters.

[18]  P. Pandolfi,et al.  BCL-6 regulates chemokine gene transcription in macrophages , 2000, Nature Immunology.

[19]  Per Eriksson,et al.  Gene Expression in Atherosclerotic Lesion of ApoE Deficient Mice , 2001, Molecular medicine.

[20]  S. Bijlsma,et al.  A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line , 2004, Proteomics.

[21]  K. Raivio,et al.  Expression of antioxidant enzymes in human inflammatory cells. , 2000, American journal of physiology. Cell physiology.

[22]  S. Tsai,et al.  Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis. , 2002, Molecular human reproduction.

[23]  S. Ylä-Herttuala,et al.  Retrovirus-mediated, stable scavenger-receptor gene transfer leads to functional endocytotic receptor expression, foam cell formation, and increased susceptibility to apoptosis in rabbit aortic smooth muscle cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[24]  T. V. van Berkel,et al.  Hepatic and extrahepatic scavenger receptors: function in relation to disease. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[26]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[27]  L. Reichardt,et al.  Association between a transmembrane protein tyrosine phosphatase and the cadherin-catenin complex , 1996, The Journal of cell biology.

[28]  M. K. Magnússon,et al.  Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia. , 2001, Blood.

[29]  Tsz Chung Au.  DNA Microarray Data Analysis , 2003 .

[30]  R. Faull,et al.  Changes in the expression of adhesion molecules as peripheral blood monocytes differentiate into peritoneal macrophages. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  W. Brück,et al.  The relative number of macrophages/microglia expressing macrophage colony‐stimulating factor and its receptor decreases in multiple sclerosis lesions , 2002, Glia.

[32]  J. Claverie.  Computational methods for the identification of differential and coordinated gene expression. , 1999, Human molecular genetics.

[33]  N. Sohár,et al.  Lysosomal Peptidases and Glycosidases in Rheumatoid Arthritis , 2002, Biological chemistry.

[34]  Roland Somogyi,et al.  Large Scale Gene Expression Analysis of Cholesterol-loaded Macrophages* , 2000, The Journal of Biological Chemistry.

[35]  Lars S Jermiin,et al.  A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13–15, a region subject to LOH and rearrangement in human carcinoma cell lines , 1998, Oncogene.